Press Releases

TALLC in the News

July 7, 2020

Dr. Damon Smith at Biotech Show Case

November 7, 2020

TALLC at the Ophthalmology Innovation Summit

July 7, 2020

TALLC Corporation Announces Grant of New SmartCelle Patent for Enhanced Ocular Delivery of TA-A001

June 3rd, 2020

Tetra Bio-Pharma and Altus Formulation Form New Company “TALLC” to Exploit TA-A001

CONTACT US

Phone: 514 883 3447

Email: info@tallcinc.com

NEWS

TALLC issues new Corporate Presentation

Dr. Damon Smith at Biotech Show Case

TALLC at the Ophthalmology Innovation Summit

TALLC Corporation Announces Grant of New SmartCelle Patent for Enhanced Ocular Delivery of TA-A001

Tetra Bio-Pharma and Altus Formulation Form New Company “TALLC” to Exploit TA-A001

Altus Publishes New Teaser for TramaFlex breakable extended release tablets. Patent protected Safer to Use TramaFlex Tablets offer true 24hr pain relief - day and night - and smooth 7 step flexible titration from 50mg to 350mg from just 3 tablets. https://lnkd.in/d9ZRJF3

Load More...
TALLC Innovation in Vision

© TALLC Inc. 2020